In a recent news release, the manufacturer announced the submission of a new drug application to the US Food and Drug Administration (FDA) and a marketing authorisation application to the European Medicines Agency (EMA) for tirzepatide for the treatment of adults with type 2 diabetes [12]
Reducing them through a mechanism with a favorable safety profile is the core rationale for longevity microdosing
Its thought to enhance the transport of glucose into cells, thereby helping in the management of blood sugar levels
in fish and meat consumers, dietary carnitine accounts for about 75% of the total carnitine content
Enhanced metabolic function: Retatrutides unique activation of glucagon receptors adds to its appeal by boosting energy expenditure and metabolic rate, contributing to overall metabolic health
Future research should explore tirzepatide and semaglutides long-term effects on cardiovascular outcomes, mortality, and quality of life across diverse populations